CBRL
Cracker Barrel Old Country Store, Inc.
CBRL has slightly lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has the edge over CBRL overall, supported by stronger valuation and stronger fundamentals.
CBRL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Stable |
CBRL's cash flow is currently healthy, and its revenue, profitability and balance sheet are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CBRL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $21.10 | -67% |
| Fair | 21x | $29.24 | -55% |
| Forward | 31x | $64.86 | — |
| Expensive | 39x | $54.48 | -16% |
| Current | 46x | $64.86 | — |
Historical ranges are pointers, not guarantees.
CBRL's PE is in its expensive range at 46x. If earnings grow as analysts expect, today's price would be 31x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
CBRL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CBRL to return to profit, with revenue holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CBRL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.10 | +50% |
| Q3 2026 | $1.40 | -32% |
| Q2 2026 | $1.15 | -55% |
| Q1 2026 | -$0.19 | -112% |
| Q4 2025 | $0.74 | -59% |
| Q3 2025 | $2.06 | +13% |
| Q2 2025 | $2.57 | -5.2% |
| Q1 2025 | $1.60 | -57% |
| Q4 2024 | $1.80 | -54% |
CBRL has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
CBRL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $849.3M | -2.2% |
| Q2 2026 | $797.4M | -2.9% |
| Q1 2026 | $874.8M | -7.9% |
| Q4 2025 | $797.2M | -5.7% |
| Q3 2025 | $868M | -2.9% |
| Q2 2025 | $821.1M | +0.5% |
| Q1 2025 | $949.4M | +1.5% |
| Q4 2024 | $845.1M | +2.6% |
CBRL's revenue is shrinking: $849M last quarter, down 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.6% | +1.1 points |
| Q2 2026 | 0.8% | -1 points |
| Q1 2026 | 0.1% | -3 points |
| Q4 2025 | -4.1% | -5 points |
| Q3 2025 | 0.5% | -2 points |
| Q2 2025 | 1.8% | +4.2 points |
| Q1 2025 | 3.1% | -0.2 points |
| Q4 2024 | 0.8% | -0.5 points |
CBRL has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over CBRL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
CBRL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $86M | +52% |
| Q2 2026 | $66.9M | +$80.5M |
| Q1 2026 | $24.5M | -59% |
| Q4 2025 | -$88.9M | -$45.6M |
| Q3 2025 | $56.8M | +157% |
| Q2 2025 | -$13.6M | -266% |
| Q1 2025 | $60M | +18% |
| Q4 2024 | -$43.3M | -$2.8M |
CBRL has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
CBRL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +45K shares |
| 1 year | +0.4% | +81.2K shares |
| 3 years | +1.3% | +280K shares |
| 5 years | -5.1% | -1.2M shares |
| Available history | -6.5% | -1.6M shares |
CBRL has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $5M |
| Q4 2022 | $12.4M |
| Q3 2022 | $58.1M |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
CBRL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.7x | Moderate |
| Q2 2026 | 4.5x | High |
| Q1 2026 | 4.8x | High |
| Q4 2025 | 3.9x | Elevated |
| Q3 2025 | 2.5x | Moderate |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 3.0x | Moderate |
| Q4 2024 | 3.3x | Elevated |
CBRL's net debt is about 2.7 years of its operating earnings (EBITDA), up from 2.5 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CBRL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.9 | Neutral |
| Stochastic | 77.0 | Neutral |
CBRL's weekly RSI is 64 (neutral) and its Stochastic is 77 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CBRL PE vs Consumer Cyclical Sector
| Metric | CBRL | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 18x | 157% above |
| PE % | 88 | 47 | 41 pts above |
CBRL is trading at 46x earnings, a 157% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
CBRL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.7 | 3.5% above |
| 20 week MA | $57.4 | 13% above |
| 50 week MA | $42.1 | 54% above |
| 100 week MA | $45.8 | 41% above |
| 200 week MA | $59.2 | 9.5% above |
CBRL has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
CBRL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $154.8 | $135.1 | -13% |
| 2021 | $135.1 | $128.1 | -5.2% |
| 2022 | $128.1 | $97.1 | -24% |
| 2023 | $97.1 | $77.1 | -21% |
| 2024 | $77.1 | $56.4 | -27% |
| 2025 | $56.4 | $26.0 | -54% |
| 2026 YTD | $26.0 | $64.9 | +150% |
CBRL has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.